Abstract Background: Serum uric acid (UA) level in end stage renal disease (ESRD) patients is an important physiological index for nutrition and inflammation. Serum UA displays a U-shape associated with all-cause mortality in ESRD patients. In this study, we evaluated relevance of serum UA level with survival rate in ESRD patients according to Charlson comorbidity index (CCI). Methods: Our cohort of2615 subjects suffer from ESRD with CCI < 4 and ≥ 4. Of the 2615 subjects, 1107 subjects are CCI < 4 and others are CCI ≥ 4. The two independent groups were individually marked by serum UA sextiles. Results: With Cox regression, serum UA levels higher than 8.6 mg/dl in the ESRD with CCI < 4 denoted as risk factor for all-cause mortality (hazard ratio (HR): 1.61, 95% CI: 1.01–2.38), compared to these subjects with UA of 7.1-7.7 mg/dl. In contrast, serum UA levels < 5.8 mg/dl represent risk factor for all-cause mortality in subjects with CCI ≥ 4 (HR: 1.53, 95% CI: 1.20–1.95) compared with UA > 8.6 mg/dl. Conclusion: Higher serum UA in ESRD subjects with high comorbidities is hardly a risk factor. Profoundly, low UA should be prevented in all ESRD patients.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: